How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

These unhygienic, offensive lumps of plastic do everything the sink does, and less. It’s time to get rid, says comedy writer Jason Hazeley ...

DNA Ginkgo Bioworks Holdings, Inc.

The New Yorker offers a signature blend of news, culture, and the arts. It has been published since February 21, 1925.

Cartoons from earlier can be viewed here.

Roz Chast was born in Brooklyn. She attended the Rhode Island School of Design, graduating with a B.F.A. in painting in 1977. Her cartoons and covers have appeared continuously in The New Yorker since ...